Somnee Secures $10M Seed Round to Pioneer Neurotech-Driven Sleep Solutions

Somnee is thrilled to announce that it has raised $10,000,000 in funding to accelerate its mission of transforming sleep and neurological health using breakthrough neuroscience technology. Developed by StimScience, Somnee is a category-defining neurotech wearable and sleep service that leverages decades of pioneering research in sleep, brain health, and personalized non-invasive neurostimulation. This new capital will be used to further commercialize our innovative “closed-loop” diagnostic and therapeutic products, designed to help individuals, athletes, researchers, clinicians, employers, and health plans achieve better sleep and improved neurological outcomes while addressing a global health challenge. With scientific rigor at its core, our interdisciplinary team—including world-renowned experts such as Dr. Matthew Walker, Ph.D., Dr. Rich Ivry, Ph.D., Dr. Robert Knight, M.D., Dr. Ram Gurumoorthy, and industry veterans from Fitbit, Google, Apple, and Samsung—has been on the forefront of sleep research and brain health for decades. This significant funding milestone, initially championed by investors like Khosla Ventures, reinforces our commitment to delivering life-changing products that improve sleep onset, minimize nighttime disruptions, and boost restorative sleep quality. As our founding Chief Science Advisor, Dr. Matthew Walker, famously stated in his bestselling book "Why We Sleep," sleep is the cornerstone of brain and body resetting each day. Today, with one in three adults suffering from insufficient sleep and over half expressing dissatisfaction with their sleep quality, our ongoing mission is more vital than ever. This investment not only accelerates our product development pipeline but also amplifies our capacity to combat the sleep health epidemic for millions around the world.